Clair Labs expects to secure its first paying customer in early 2023
Adi Berenson · HealthTech Device Prevents COPD Patients from Hospital Visits, $9m Raised, 50 Devices Shipped · Dec 28, 2021 · at 18:36
Adi Berenson, CEO of Clair Labs, explains the timeline for gaining reimbursement-based healthcare revenue in the US due to FDA clearance requirements.
0:00 / 0:31exact quote · 31.3s
720p mp4 · rendered on demand · StarZero watermark
“Early 20 23. Yes. Wow. Yeah. I mean, it's a long, no, no, no. It's because you need in order to realistically, not realistically, in order to make business reimbursement based business, not out of pocket business, reimbursement based business in healthcare in the US, you need to have FDA. In order to have FDA, you need to complete clinical trials. You need to do submission and you need to wait for clearance. So Yeah. I mean, I'm a very realistic person. I can say twenty-twenty-two, but I can guarantee twenty-twenty-three.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Adi Berenson
Clair Labs detects 95% of COPD hospitalizations seven to eight days early
“What we are showing is Is that we are raising the, an accurate alarm flag seven to eight days before very, I mean, in very high rates, like 95%, ok? 95% of the hospitalization cases of the clinical trials of the sample we sampled. We are showing a very obvious…”
Wearables fail for elderly patients due to charging and pairing noncompliance
“So number one problem with COPD patients, and with other chronic patients, especially elderly, is compliance. Everything that requires them to take action, which is charging, putting it back on, tolerating it even, pairing it with the phone, is Is, is going to…”
Clair Labs uses near-infrared to measure pulse and respiration contact-free
“And then by looking at your skin in two waves of near infrared, it can see movements of superficial arteries. So arteries that are very close to the surface by looking at those arteries, we see volumetric changes and we see tone changes. And then we are actual…”
Medicare and major payers reimburse Clair Labs' remote patient monitoring services
“The way it works, the business model, is that our customers are providers, our healthcare providers, and they are offering it under, I will call, an umbrella of RPM, remote patient monitoring services, which is reimbursed by Medicare and all major healthcare p…”